Morepen Laboratories Limited
MOREPENLAB
Rank in Stocks
#11314
Morepen Laboratories Limited is an Indian pharmaceutical company primarily... Morepen Laboratories Limited is an Indian pharmaceutical company primarily engaged in the development, manufacturing, marketing, and distribution of active pharmaceutical ingredients (APIs), proprietary and generic pharmaceutical formulations, and a diverse range of home healthcare products. Its API portfolio encompasses compounds utilized in the creation of drugs for conditions such as allergies, asthma, elevated cholesterol, hypertension, and diabetes. The company also supplies an array of point-of-care and medical devices for home use, including diagnostic tools like air purifiers, thermometers, stethoscopes, blood pressure monitors, pulse oximeters, nebulizers, glucometers with accompanying strips, as well as hygiene products such as sanitizers, disinfectant solutions, masks, and gloves. Among its well-known branded products are Burnol, a cream for treating burns; Lemolate, an offering for cough and cold relief; and Fiber-X, a psyllium husk supplement. Furthermore, Morepen produces finished drug formulations covering various therapeutic areas, including gastrointestinal health, antibiotics, vitamins, nutritional support, anti-diabetics, and cardiovascular conditions. Beyond these offerings, the company undertakes contract manufacturing for other businesses and participates in brand sharing agreements. Its comprehensive range of over-the-counter (OTC) products is marketed under the recognizable Dr. Morepen brand. The company's global footprint extends to approximately 75 nations, where its products are exported. Established in 1984, Morepen Laboratories Limited maintains its headquarters in New Delhi, India.
Share Price
$1.06
Last synced: 2026-11-09
Market Cap
$578.30M
Change (1 day)
8.07%
Change (1 year)
98.63%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Morepen Laboratories Limited (MOREPENLAB)
Category
Healthcare
Operating Margin for Morepen Laboratories Limited (MOREPENLAB)
Operating Margin as of November 2026 TTM: 10.58%
According to Morepen Laboratories Limited's latest financial reports, its current operating margin (TTM) is 10.58%. At the end of 2025 the company had an operating margin of 17.26%.
Operating Margin history for Morepen Laboratories Limited from 2005 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 10.58% | -38.70% |
| 2025 | 17.26% | -29.61% |
| 2024 | 24.52% | 616.96% |
| 2023 | 3.42% | -57.99% |
| 2022 | 8.14% | 3.56% |
| 2021 | 7.86% | 78.64% |
| 2020 | 4.40% | 9.18% |
| 2019 | 4.03% | -20.83% |
| 2018 | 5.09% | -2.86% |
| 2017 | 5.24% | -7.26% |
| 2016 | 5.65% | 118.15% |
| 2015 | 2.59% | 194.32% |
| 2014 | 0.88% | -121.26% |
| 2013 | -4.14% | -58.43% |
| 2012 | -9.96% | -44.79% |
| 2011 | -18.04% | 4.76% |
| 2010 | -17.22% | -32.52% |
| 2009 | -25.52% | -34.68% |
| 2008 | -39.07% | 57.67% |
| 2007 | -24.78% | -35.97% |
| 2006 | -38.70% | -34.64% |
| 2005 | -59.21% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -98.17% |
DE
|
|
| 19.68% | -98.14% |
DE
|
|
| 13.26% | -98.75% |
JP
|
|
| 17.08% | -98.39% |
CH
|
|
| 14.92% | -98.59% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Morepen Laboratories Limited's operating margin
What is Morepen Laboratories Limited's operating margin?
Morepen Laboratories Limited's operating margin is 10.58%, as of Nov 2026.
What was Morepen Laboratories Limited's operating margin in 2025?
In 2025, Morepen Laboratories Limited's operating margin was 17.26%, compared with 24.52% in 2024.
How has Morepen Laboratories Limited's operating margin changed since 2020?
From 2020 to 2025, Morepen Laboratories Limited's operating margin was highest in 2024 (24.52%) and lowest in 2023 (3.42%).
How does Morepen Laboratories Limited's operating margin compare with similar companies?
Morepen Laboratories Limited's operating margin (10.58%) is lower than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.